A recent Nature article reports a preclinical GLP-1GIPlanifibranor conjugate: a unimolecular quintuple agonist designed to combine GLP-1R/GIPR co-agonism with PPAR// agonism
XYZ: Investigation, Writing review & editing, Methodology, Validation
Participants who took semaglutide (Ozempic) over the course of 68 weeks in a clinical trial lost an average of 15% of their body weight
This study suggested that Epithalon might have the potential to modify the chromosome regions in the aging cells, activate chromatin, and restore cellular activities that were otherwise suppressed or delayed in geriatric subjects
Together or individually, they function best within a structured, clinically guided plan
Synergistic Hydration: The phospholipid vehicle itself repairs the skin barrier and improves hydration levels